Items where authors include "Joshi, M."

Jump to: Article
Number of items: 10.

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Dey, M., Doskaliuk, B., Parodis, I. et al. (18 more authors) (2024) COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey. Rheumatology International, 44 (12). pp. 2853-2861. ISSN 0172-8172

Alunno, A., Carubbi, F., Tan, A.L. orcid.org/0000-0002-9158-7243 et al. (13 more authors) (2024) COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study. Rheumatology International, 44 (9). pp. 1725-1731. ISSN 0172-8172

Andreoli, L., Lini, D., Schreiber, K. et al. (184 more authors) (2024) COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study. Rheumatology, 63 (5). pp. 1341-1351. ISSN 1462-0324

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Dave, R.V. orcid.org/0000-0001-6827-8090, Barrett, E., Morgan, J. orcid.org/0000-0002-5337-5581 et al. (86 more authors) (2022) Wire- and magnetic-seed-guided localization of impalpable breast lesions: iBRA-NET localisation study. British Journal of Surgery, 109 (3). pp. 274-282. ISSN 0007-1323

Sievert, K-D., Chapple, C. orcid.org/0000-0002-2960-9931, Herschorn, S. et al. (4 more authors) (2014) OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder. International Journal of Clinical Practice, 68 (10). pp. 1246-1256. ISSN 1368-5031

Alner, G.J., Araujo, H.M., Bewick, A. et al. (60 more authors) (2007) Limits on spin-dependent WIMP-nucleon cross-sections from the first ZEPLIN-II data. Physics Letters B, 653 (2-4). pp. 161-166. ISSN 0370-2693

This list was generated on Wed Apr 2 07:53:33 2025 BST.